KR100585613B1 - External application composition containing ?-1,3-glucan and ginseng saponin - Google Patents
External application composition containing ?-1,3-glucan and ginseng saponin Download PDFInfo
- Publication number
- KR100585613B1 KR100585613B1 KR1019990065695A KR19990065695A KR100585613B1 KR 100585613 B1 KR100585613 B1 KR 100585613B1 KR 1019990065695 A KR1019990065695 A KR 1019990065695A KR 19990065695 A KR19990065695 A KR 19990065695A KR 100585613 B1 KR100585613 B1 KR 100585613B1
- Authority
- KR
- South Korea
- Prior art keywords
- glucan
- skin
- beta
- composition
- ginseng saponin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Abstract
본 발명은 베타-1,3-글루칸과 인삼사포닌을 함유하는 외용제 조성물에 관한 것이다. 보다 상세하게는 베타-1,3-글루칸과 인삼 사포닌을 최적의 비율로 조합함으로써 피부세포 증식, 콜라겐섬유 합성촉진 등 피부 주름개선 및 탄력증진 효과가 우수한 외용제 조성물을 제공할 수 있다.The present invention relates to an external preparation composition containing beta-1,3-glucan and ginseng saponin. In more detail, by combining beta-1,3-glucan and ginseng saponin in an optimal ratio, it is possible to provide an external preparation composition having excellent skin wrinkle improvement and elasticity enhancing effects such as skin cell proliferation and collagen fiber synthesis promotion.
베타-1,3-글루칸, 인삼사포닌, 피부노화 방지, 주름개선, 탄력증진Beta-1,3-glucan, ginseng saponin, skin aging prevention, wrinkle improvement, elasticity improvement
Description
본 발명은 베타-1,3-글루칸과 인삼사포닌을 함유하는 피부 외용제 조성물에 관한 것이다.The present invention relates to an external composition for skin containing beta-1,3-glucan and ginseng saponin.
피부는 인체의 일차 방어막으로서 온도 및 습도의 변화, 자외선, 공해물질 등과 같은 외부환경의 자극으로부터 체내의 제기관을 보호해 주는 기능을 한다. 그러나, 내적으로는 나이가 들어감에 따라 신진대사를 조절하는 각종 호르몬의 분비가 감소하고, 면역 세포의 기능과 세포들의 활성이 저하되어 생체에 필요한 면역 단백질 및 생체 구성 단백질들의 생합성이 줄어들게 되고, 외적으로는 오존층 파괴로 인한 피부에 도달하는 태양 광선의 자외선 증가와 같은 환경오염이 더욱 심화됨에 따라 자유 라디칼 및 활성 유해 산소 등이 증가함으로써 생기는 과도한 물리적, 화학적 자극 및 스트레스 등으로 인하여 피부의 정상기능이 저하되고 피부의 노화현상이 촉진되어 피부가 손상되게 된다. 이러한 현상을 방지하여 보다 건강하고 아름다운 피부를 유지하기 위하여, 종래 각종 동물, 식물, 미생물 등으로부터 얻은 생리 활성 물질들을 화장품에 부가하여 사용함으로써 피부의 고유기능을 유지시키 고 피부세포를 활성화시켜 피부노화를 효과적으로 억제하기 위한 노력이 있어 왔었다.The skin is the body's primary barrier, protecting the organs of the body from stimuli of the external environment, such as changes in temperature and humidity, ultraviolet rays, and pollutants. However, internally, as hormones age, the secretion of various hormones that regulate metabolism decreases, and the function and function of cells of immune cells decreases, thus reducing the biosynthesis of immune proteins and bioconstituent proteins necessary for the living body. As environmental pollution, such as increased ultraviolet rays of the sun's rays reaching the skin due to the destruction of the ozone layer, becomes more severe, the normal functioning of the skin is caused by excessive physical and chemical irritation and stress caused by the increase of free radicals and free radicals. Decreases and accelerates the aging of the skin to damage the skin. In order to prevent this phenomenon and maintain healthy and beautiful skin, by using physiologically active substances obtained from various animals, plants, and microorganisms in the past, cosmetics are used to maintain the unique function of the skin and to activate skin cells. Efforts have been made to effectively suppress
그러나, 기존의 원료들은 그 효능이 미흡하거나 피부 부작용을 유발하는 등 여러 가지 문제점을 가지고 있다.However, existing raw materials have various problems such as insufficient efficacy or cause skin side effects.
이에 본 발명자들은 피부노화의 주된 지표가 되는 피부세포의 재생감소, 콜라겐 합성 저하 등과 같은 현상들을 억제시킬 수 있는 물질에 관하여 연구하던 중, 베타-1,3-글루칸이 피부세포의 증식 및 콜라겐 섬유의 생성촉진 작용, 일광화상치유 등의 피부기능 활성촉진 작용을 갖는다는 것을 발견하고, 이를 함유한 피부노화 방지 및 피부손상 치유에 우수한 효과를 갖는 외용제 조성물에 대해 특허를 출원한 바 있다(한국특허출원 98-49026호).Therefore, while the present inventors are studying a substance capable of inhibiting phenomena such as a decrease in the regeneration of skin cells and a decrease in collagen synthesis, which are major indicators of skin aging, beta-1,3-glucan is a proliferation of collagen fibers and collagen fibers. It has been found that it has the action of promoting the function of the skin, such as promoting the production of the sun, healing of sunburn, etc., and has applied for a patent for an external preparation composition having an excellent effect on preventing skin aging and healing of skin damage containing the same (Korean patent) Application 98-49026).
그러나, 본 발명자들은 베타-1,3-글루칸의 상기한 효능을 더욱 상승시키기 위하여, 기존의 피부 노화 방지 물질들과의 병용 효과 및 보다 효율적인 피부노화 방지 외용제의 조성에 대해 더욱 광범위하게 연구, 검토하게 되었고 그 결과, 피부의 모세혈관에서 혈액순환을 증진시켜 표피에의 영양분 공급을 원활하게 하고 진피 결합조직의 글리코사미노글리칸(Glycosaminoglycan)의 합성을 촉진하며 항염증 효과가 있다는 것으로 공지된 인삼 사포닌 성분과 분지-베타-1,3-글루칸을 동시에 사용할 경우, 이들 조합 조성물이 피부노화를 효과적으로 억제하고, 피부 탄력을 개선한다는 사실을 발견하고, 피부주름 개선 및 피부 탄력 개선 효과가 탁월한 피부 외용제 조성물을 발명하게 되었다. However, in order to further enhance the above-mentioned efficacy of beta-1,3-glucan, the present inventors have studied and examined more extensively about the combination effect with existing skin anti-aging substances and the composition of a more effective anti-aging external preparation. As a result, ginseng is known to promote blood circulation in the capillaries of the skin to facilitate the supply of nutrients to the epidermis, promote the synthesis of glycosaminoglycans in the dermal connective tissue, and have an anti-inflammatory effect. When both saponin and branched-beta-1,3-glucan are used simultaneously, they find that the combination composition effectively suppresses skin aging, improves skin elasticity, and is a skin external preparation that is excellent in improving wrinkles and improving skin elasticity. Invented the composition.
따라서, 본 발명의 목적은 베타-1,3-글루칸과 인삼 사포닌을 함유하여 피부노화를 방지하는 외용제 조성물을 제공하는 것이다.Accordingly, it is an object of the present invention to provide an external preparation composition containing beta-1,3-glucan and ginseng saponin to prevent skin aging.
즉, 본 발명의 목적은 베타-1,3-글루칸과 인삼사포닌이 갖는 우수한 피부주름개선 및 탄력증진기능을 이용한 것으로서, 이 성분들의 복합적 상승작용효과를 활용하여 피부 외용제 조성물을 제공함을 목적으로 한다.That is, an object of the present invention is to use the excellent skin wrinkle improvement and elasticity promoting function of beta-1,3-glucan and ginseng saponin, and to provide an external composition for skin by utilizing the complex synergistic effect of these components. .
앞서 기술한 목적을 달성하기 위하여, 본 발명에 따른 외용제 조성물은 조성물의 총 중량에 대하여 베타-1,3-글루칸을 0.00001∼10중량%의 양으로 함유하고, 인삼사포닌을 0.00001∼10중량%의 양으로 함유하는 것을 특징으로 한다.In order to achieve the above object, the external preparation composition according to the present invention contains beta-1,3-glucan in an amount of 0.00001 to 10% by weight, and ginseng saponin of 0.00001 to 10% by weight based on the total weight of the composition. It is characterized by containing in an amount.
본 발명에 사용되는 베타-1,3-글루칸은 특히, 치마버섯(Schizopyllum commune) 균사체를 액체 배양하여 얻은 순도 98% 이상의 고순도의 글루칸이 적당한데 이것은 피부 노화 방지, 손상된 피부 치유 효과가 있다. 치마버섯 이외에도 영지버섯, 신령버섯, 표고버섯, 균핵균, 효모, 보리 등을 배양하여 얻은 베타-1,3-글루칸을 사용할 수 있다.Beta-1,3-glucan used in the present invention is particularly suitable for high purity glucan with a purity of 98% or more obtained by liquid culture of Schizopyllum commune mycelium, which has an anti-aging and damaged skin healing effect. In addition to the skirt mushroom, beta-1,3-glucan obtained by culturing Ganoderma lucidum mushroom, Shiitake mushroom, shiitake mushroom, yeast, barley and the like can be used.
한편, 인삼사포닌은 인삼의 주요 화학적 성분으로서, 진세노 사이드라 불리며, 다른 식물에 함유되어 있는 사포닌 성분과는 달리 용혈작용과 같은 독성을 거의 일으키지 않으면서 다양한 생물활성을 발휘할 수 있다.On the other hand, ginseng saponin is the main chemical component of ginseng, called ginsenosides, unlike the saponin components contained in other plants can exhibit a variety of biological activities with little toxicity, such as hemolytic action.
본 발명의 외용제 조성물은 상기한 베타-1,3-글루칸과 인삼 사포닌을 각각 조성물 총 중량에 대하여 0.00001∼10중량%, 바람직하게는 0.001∼5중량%의 양으로 함유한다. 함량을 상기와 같이 제한하여야 하는 이유는 경제성과 효능의 상관 관계 때문인데, 함량이 10%를 초과할 경우 효능이 더 이상 증가하지 않기 때문에 경제적으로 이점이 없고, 함량이 적어 0.00001% 미만일 경우 충분한 효과를 내지않는 문제점이 있기 때문이다.The external preparation composition of the present invention contains beta-1,3-glucan and ginseng saponin in an amount of 0.00001 to 10% by weight, preferably 0.001 to 5% by weight based on the total weight of the composition. The reason for limiting the content as described above is because of the correlation between economic efficiency and efficacy. When the content is more than 10%, the effect is no longer increased, so there is no economic advantage, and when the content is less than 0.00001%, sufficient effect This is because there is a problem that does not give.
본 발명의 피부 외용제 조성물은 그 제형에 있어서 특별히 한정되는 바가 없으며, 예를 들면, 유연화장수, 영양화장수, 마사지크림, 영양크림, 팩, 젤 또는 피부 점착타입의 화장료의 제형을 갖는 화장료 조성물일 수 있으며, 또한, 로션, 연고, 겔, 크림, 패취 또는 분무제와 같은 경피투여형 제형일 수 있다.The external preparation composition for skin of the present invention is not particularly limited in its formulation, and may be, for example, a cosmetic composition having a formulation of a flexible cosmetic water, a nourishing cosmetic water, a massage cream, a nourishing cream, a pack, a gel, or a skin adhesive type cosmetic. And may also be transdermal formulations such as lotions, ointments, gels, creams, patches or sprays.
또한 각 제형의 외용제 조성물에 있어서, 상기한 인삼사포닌과 베타-1,3-글루칸 이외에 다른 성분들은 기타 외용제의 제형 또는 사용목적 등에 따라 당업자가 어려움 없이 적의 선정하여 배합할 수 있다.In addition, in the external preparation composition of each formulation, other components in addition to the above-mentioned ginseng saponin and beta-1,3-glucan can be appropriately selected and blended by those skilled in the art without difficulty according to the formulation or purpose of use of other external preparations.
본 발명의 실시예 및 시험예를 들어 본 발명의 구성 및 작용효과를 보다 구체적으로 설명한다. 그러나 본 발명의 실시예 또는 시험예는 본 발명을 보다 상세하게 설명하기 위한 것으로서 본 발명이 그 실시예 또는 시험예에 한정되지 않는다.Examples and test examples of the present invention will be described in more detail the configuration and effect of the present invention. However, the examples or test examples of the present invention are intended to explain the present invention in more detail, and the present invention is not limited to the examples or test examples.
<시험예 1><Test Example 1>
사람의 섬유 아세포의 증식효과 측정Measurement of proliferative effect of human fibroblasts
본 발명의 시험예 및 실시예에서 사용한 베타-1,3-글루칸은 치마버섯 (Schizopyllum commune) 균사체를 액체배양하여 얻은 순도 98% 이상의 고순도 베 타-1,3-글루칸이며, 인삼사포닌은 한국인삼공사(한국인삼연초연구소 제조)에서 공급하는 것으로서, 조사포닌 함량이 9.9%인 것이었다.Beta-1,3-glucan used in Test Examples and Examples of the present invention is a high purity beta-1,3-glucan obtained by liquid culture of Schizopyllum commune mycelium with a purity of 98% or higher, and ginseng saponin is Korean ginseng It was supplied by the Corporation (manufactured by Korea Ginseng and Tobacco Research Institute) and had a content of irradiated ponin 9.9%.
인삼 사포닌과 상기 베타-1,3-글루칸은 섬유아세포의 배양배지를 사용하여 하기 표 1의 농도로 희석하여 시험에 사용하였다.Ginseng saponin and the beta-1,3-glucan were used in the test by diluting to the concentration of Table 1 using a culture medium of fibroblasts.
인체에서 직접 채취한 인간의 섬유아세포에 0.01%로 희석한 인삼사포닌(시료 1)을 처리한 군, 0.04%로 희석한 베타-1,3-글루칸(시료 2)을 처리한 군, 그리고 베타-1,3-글루칸과 인삼사포닌을 적량씩 혼합한 조성물(시료 3 내지 7)들을 처리한 군에서의 섬유 아세포의 증식 효과를 측정하였다. A group treated with ginseng saponin (Sample 1) diluted to 0.01% in human fibroblasts collected directly from the human body, a group treated with beta-1,3-glucan (Sample 2) diluted to 0.04%, and a beta- The proliferative effect of fibroblasts in the group treated with the composition (Samples 3 to 7) in which 1,3-glucan and ginseng saponin were mixed in appropriate amounts was measured.
1) 시험방법1) Test method
2.5%의 우태아 혈청이 함유된 DMEM(Dulbecco's Modified Eagle's Media)배지에서 배양한 사람의 섬유 아세포를 96웰 평판배양기(96-well microtiter plate)에 5,000세포/well가 되도록 분주하였다. 상기 표 1의 시료들을 3일간 하루에 2회 100㎕씩 처리하여 배양 한 후, 0.2%의 MTT(3-[4,5-dimethylthiazol-2-yl]-2, 5-phenyltertazolium bromide) 용액을 각 웰(well)당 50㎕씩 첨가하고, 다시 37℃ 온도에서 4시간동안 배양한 후, 생성된 포르마잔(formazan; 미토콘드리아의 탈수소 효소(dehydrogenase)와 MTT가 반응하여 생긴 산물)을 DMSO(Dimethyl sulfoxide)를 사용하여 용해시켰다. 용해된 포르마잔의 흡광도를 평판배양측정기(microplate reader)를 이용하여 570nm에서 측정하였다. 이때 시료를 처리하지 않은 군을 대조군으로 사용하였다.Human fibroblasts incubated in Dulbecco's Modified Eagle's Media (DMEM) medium containing 2.5% fetal calf serum were dispensed at 96 cells / well in a 96-well microtiter plate. After incubating the samples of Table 1 by treating 100 μl twice a day for 3 days, 0.2% MTT (3- [4,5-dimethylthiazol-2-yl] -2, 5-phenyltertazolium bromide) solution was prepared. 50 μl per well was added, followed by further incubation at 37 ° C. for 4 hours, and then DMSO (dimethyl sulfoxide) was produced from the resultant formazan (product produced by the reaction of dehydrogenase of mitochondria with MTT). ) Was dissolved. The absorbance of the dissolved formazan was measured at 570 nm using a microplate reader. At this time, the group not treated with the sample was used as a control.
이렇게 하여 측정한 흡광도를 이용하여 상기 시료들의 섬유 아세포 증식 촉진효과를 알 수 있는데, 세포가 증식되어 세포의 양이 증가되면 흡광도 또한 증가하기 때문에 흡광도가 세포의 양과 비례하기 때문이다. 증식효과를 구하는 방법은 대조군의 흡광도와 각각의 시료에서의 흡광도를 비교하여 아래방법에 의해 계산하였다.The absorbance measured in this way can be used to determine the fibroblast proliferation promoting effect of the samples, since the absorbance also increases when the cells are grown and the amount of cells increases, so the absorbance is proportional to the amount of cells. The proliferation effect was calculated by comparing the absorbance of the control group with the absorbance of each sample by the following method.
2) 실험결과2) Experiment result
각 시료에서의 증식효과는 표 2에 나타나 있다. 표 2에서 알 수 있는 바와 같이, 각각의 시료로 처리된 경우 섬유 아세포의 증식이 발견되었는데, 베타-1,3-글루칸과 인삼사포닌을 동시에 사용할 경우, 각각을 단독으로 사용할 때 보다 섬유아세포의 증식효과가 상승한다는 것을 알 수 있다. 특히 시료 7 즉, 베타-1,3-글루칸과 인삼사포닌을 각각 1.0%와 0.5%의 농도로 사용할 경우, 섬유 아세포의 증식효과는 78%에 이르렀다.The proliferative effect in each sample is shown in Table 2. As can be seen in Table 2, fibroblast proliferation was found when treated with each sample. When beta-1,3-glucan and ginseng saponin were used simultaneously, the proliferation of fibroblasts was higher than when each was used alone. It can be seen that the effect is increased. In particular, when sample 7, i.e., beta-1,3-glucan and ginseng saponin, was used at concentrations of 1.0% and 0.5%, respectively, the proliferative effect of fibroblasts reached 78%.
<시험예 2><Test Example 2>
사람의 표피세포의 증식효과 측정Measurement of proliferative effect of human epidermal cells
인체에서 직접 채취한 사람의 표피 세포에 시험예 1에서 같은 시료를 동일한 방법으로 처리하고, 동일한 방법에 의해 표피 세포의 증식 효과를 측정하였다.Epidermal cells of humans directly collected from the human body were treated with the same method in Test Example 1, and the proliferative effect of the epidermal cells was measured by the same method.
그 결과는 표 3에 나타나 있다. 표 3에서 보는 바와 같이, 시험예 1과 마찬가지로 각각의 시료로 처리된 경우에 표피세포의 증식이 발견되었는데, 베타-1,3-글루칸과 인삼사포닌을 동시에 사용한 경우, 각각을 단독으로 사용할 때 보다 표피세포의 증식이 상승한다는 것을 알 수 있다. 특히, 시료 7 즉, 베타-1,3-글루칸과 인삼사포닌을 각각 1.0%와 0.5%의 농도로 사용할 경우, 표피세포의 증식효과는 55 %에 이르렀다.The results are shown in Table 3. As shown in Table 3, proliferation of epidermal cells was found when treated with each sample as in Test Example 1, but when beta-1,3-glucan and ginseng saponin were used simultaneously, It can be seen that the proliferation of epidermal cells is elevated. In particular, when sample 7, i.e., beta-1,3-glucan and ginseng saponin, was used at concentrations of 1.0% and 0.5%, respectively, the proliferation effect of epidermal cells reached 55%.
<시험예 3><Test Example 3>
사람의 섬유 아세포에서의 콜라겐 생성 촉진효과 측정Measurement of Collagen Production Promoting Effect in Human Fibroblasts
인체에서 직접 채취한 사람의 섬유 아세포에 시험예 1과 동일한 시료들을 처리하여 콜라겐 단백질의 생성 효과를 측정하였다.Human fibroblasts collected directly from the human body were treated with the same samples as in Test Example 1 to determine the effect of collagen protein production.
1)시험방법1) Test Method
인체 섬유 아세포를 24웰 평판배양기에 배양한 후, 상기 표 1의 각 시료들을 배양배지에 첨가하였다. 배양 3일째 10%의 우태아 혈청이 함유된 DMEM배지를 각 웰(well)당 0.5㎖씩 첨가한 후 L[2, 3, 4, 5-3H]-프롤린 10μCi를 첨가하였다. 24시간 후 각 웰(well)에 들어있는 배지와 세포들을 긁어모아 5% 트리클로로아세틱에시드(TCA; trichloroacetic acid) 용액에 넣어 세척한 후 2개의 시험관에 분주하였다. 각각의 시험관에 타입 I 콜라게나제(type I collagenase) 1unit/㎕를 넣고, 하나는 37℃ 온도에서 90분간 배양하였으며, 다른 시험관은 4℃에서 보관하였다. 그후 모든 시험관에 50% TCA를 0.05㎖씩 첨가하고 4℃에서 20분간 방치한 후 각각 12,000rpm에서 10분간 원심분리하여 각각의 상층액과 침전물을 액체 신틸레이션 계수기(LSC; Liquid Scintillation Counter)로 디피엠(dpm; decay per minute) 값을 얻어 하기 수학식 2에 의거하여 콜라겐 생합성 값(RCB; Relative Collagen Biosynthesis)을 구하였다.After culturing human fibroblasts in a 24-well plate incubator, each sample of Table 1 above was added to the culture medium. On the third day of culture, 0.5 ml of DMEM medium containing 10% fetal calf serum was added to each well, and then 10 μCi of L [2, 3, 4, 5- 3 H] -proline was added. After 24 hours, the media and cells contained in each well were scraped, washed in 5% trichloroacetic acid (TCA) solution, and dispensed into two test tubes. 1 unit / μl of type I collagenase was added to each test tube, one was incubated at 37 ° C. for 90 minutes, and the other test tube was stored at 4 ° C. Thereafter, 0.05 ml of 50% TCA was added to all test tubes, and the mixture was allowed to stand at 4 ° C. for 20 minutes, followed by centrifugation at 12,000 rpm for 10 minutes, respectively. (dpm; decay per minute) to obtain a collagen biosynthesis value (RCB; Relative Collagen Biosynthesis) based on the following equation (2).
상기의 식은 콜라겐 생합성 값을 구하기 위한 일반적인 식으로서 "Webster & Harvey, 1979, Anal. Biochem 96, 220∼224"에 나타나 있다. 상기 식에서 계산한 값은 각 시료의 경우 대조군보다 콜라겐의 생성이 증가된 양을 %단위로 나타낸 것이다.The above formula is shown in "Webster & Harvey, 1979, Anal. Biochem 96, 220-224" as a general formula for obtaining collagen biosynthesis values. The value calculated in the above formula represents the amount of collagen production increased in units of% compared to the control for each sample.
2) 시험결과2) Test result
실험결과는 표 4에 나타나 있다. 표 4에서 알 수 있는 바와 같이, 베타-1,3-글루칸과 인삼사포닌을 동시에 사용할 경우, 각각을 단독으로 사용할 때 보다 콜라겐 생성효과가 상승한다는 것을 알 수 있다.The experimental results are shown in Table 4. As can be seen in Table 4, beta-1,3-glucan and ginseng saponin at the same time, it can be seen that the collagen production effect is increased than when using each alone.
<시험예 4><Test Example 4>
동물실험을 통한 콜라겐 생성 촉진 효과Collagen production promoting effect through animal experiment
1) 실시예 1 및 비교예 1∼3의 수중유(oil in water: O/W) 제형의 제조1) Preparation of oil in water (O / W) formulations of Examples 1 and Comparative Examples 1 to 3
실시예 1 및 비교예 1∼3에서 수중유(O/W)제형의 제조를 위한 각 성분의 조성비는 표 5와 같다.The composition ratio of each component for manufacture of oil-in-water (O / W) formulation in Example 1 and Comparative Examples 1-3 is shown in Table 5.
원료 1∼5를 혼합하여 70℃에서 용해하여 물파트로 하였다. 한편 원료 6∼13을 70℃에서 용해하여 오일파트로 하였다. 오일파트를 물파트에 첨가한 후, 호모믹서로 교반하여 유화하고 원료 14를 첨가하여 점증하였다. 기포를 제거한 후, 실온으로 냉각시켜 제조된 수중유(O/W) 제형을 실시예 1 및 비교예 1∼3으로 사용하였다.The raw materials 1-5 were mixed, melt | dissolved at 70 degreeC, and it was set as the water part. On the other hand, raw materials 6-13 were melt | dissolved at 70 degreeC, and it was set as the oil part. The oil part was added to the water part, and then stirred with a homomixer to emulsify. After removing the bubbles, oil-in-water (O / W) formulation prepared by cooling to room temperature was used in Examples 1 and Comparative Examples 1-3.
2) 콜라겐 생성 시험방법2) Collagen Production Test Method
무모 생쥐(hairless mouse)에 자외선을 8주간 매일 1회 (UVB 70mJ/cm2)조사한 후, 실시예 1 밀 비교예 1∼3을 적용할 군을 정해서 각 군당 20마리씩 2군으로 나누어, 상기에서 제조한 실시예 1 및 비교예 1∼3을 각각 1달간 매일 100㎕씩 등 부위에 도포한 후 생검하여 H&E 염색법(Kligman, 1982, J.I.D. 78, p181∼189)을 이용하여 조직학적으로 콜라겐의 형성정도를 측정하였다.Hairless mice were irradiated with UV rays once daily for 8 weeks (UVB 70mJ / cm 2 ), and then the groups to which the Comparative Examples 1 to 3 were applied were divided into 2 groups of 20 animals in each group. Prepared Example 1 and Comparative Examples 1 to 3 each day for 1 month to 100μl daily applied to the back area and biopsied by the H & E staining method (Kligman, 1982, JID 78, p181 ~ 189) to form histologically collagen The degree was measured.
본 시험예에서는 시험동물이 무모 생쥐에 자외선을 조사하였다. 자외선은 콜라겐 생성을 저하시킬 뿐 아니라 콜라겐 분해를 촉진하는데 이것이 광노화로서 이렇게 자외선이 조사된 조건하에서 콜라겐 생성을 알아보기 위해서 자외선을 조사한 무모 생쥐의 조직에서 콜라겐 생성정도를 측정한 것이다.In this test example, test animals irradiated UV light on hairless mice. Ultraviolet rays not only degrade collagen production but also promote collagen degradation, which is photoaging, which measures the degree of collagen production in tissues of hairless mice irradiated with UV light to detect collagen production under such UV-irradiated conditions.
3) 결과3) results
콜라겐 생성률은 이미지 어낼라이저(Image Analyzer)를 사용하여 구하였는데, 이미지 어낼라이저가 H&E 염색부위의 색상을 분석하여 염색 정도를 측정하여 수치화 함으로써 콜라겐 생성률의 값을 구할 수 있었다.Collagen production rate was calculated using an image analyzer. The collagen production rate was determined by quantifying the staining degree by analyzing the color of the H & E staining site.
결과는 표 6에 나타나 있다. 표 6에서 보는 것처럼 본 발명에 의한 외용제 조성물에 의해 콜라겐의 생성이 증가되어 피부 보호에 효과를 나타냄을 알 수 있다.The results are shown in Table 6. As shown in Table 6, it can be seen that the production of collagen is increased by the external preparation composition according to the present invention, which has an effect on skin protection.
<시험예 5><Test Example 5>
인체 피부를 대상으로 한 피부주름 개선효과Skin wrinkle improvement effect on human skin
1) 실시예 2 및 비교예 4∼6의 수중유(O/W) 제형의 제조1) Preparation of oil-in-water (O / W) formulations of Examples 2 and Comparative Examples 4-6
실시예 2 및 비교예 4∼6에서 O/W 제형의 제조를 위한 각 성분의 조성비는 하기 표 7과 같다.In Example 2 and Comparative Examples 4 to 6, the composition ratio of each component for preparing the O / W formulation is shown in Table 7 below.
원료 1∼6을 혼합하여 70℃에서 용해하여 물파트로 하였다. 한편 원료 7∼14를 70℃에서 용해하여 오일파트로 하였다. 오일파트를 물파트에 첨가한 후, 호모믹서로 교반하여 유화하고 원료15를 첨가하여 점증하였다. 기포를 제거한 후, 실온으로 냉각시켜 실시예 2 및 비교예 4∼6으로 사용하였다.The raw materials 1-6 were mixed, melt | dissolved at 70 degreeC, and it was set as the water part. On the other hand, raw materials 7-14 were melt | dissolved at 70 degreeC, and it was set as the oil part. The oil part was added to the water part, stirred with a homomixer to emulsify, and the raw material 15 was added to increase. After removing the bubbles, the mixture was cooled to room temperature and used in Examples 2 and 4-6.
2) 주름 개선 효과 시험방법2) Wrinkle improvement effect test method
위의 비교예 및 실시예에서 제조된 화장료에 대한 피부 주름 개선 효과를 비교하였다. 피부의 주름 개선 효과는 30∼40대 여성 180명을 대상으로 9개조로 나누어 측정하였다. 시험 방법은 아래와 같다.The skin wrinkle improvement effect of the cosmetics prepared in Comparative Examples and Examples above was compared. Wrinkle improvement effect of skin was measured by dividing nine groups of 180 women in their 30s to 40s. The test method is as follows.
각 조에 실시예 2와 비교예 4∼6에서 제조된 제품을 주고 매일 1회 1개월간 도포하게 한 후, 1개월이 지난 다음 실리콘을 이용하여 replica를 뜨고 visiometer (SV500, Courage+Khazaka electronic GmbH, Germany)를 이용한 화상 분석을 통하여 주름의 깊이를 측정하여 주름의 감소정도를 평가하였고, 피부 탄력을 측정할 수 있는 cutometer(SEM474, Courage+Khazaka electronic GmbH, Germany )를 이용하여 얼굴 부위의 탄력을 측정하여 도포하기 전과 비교하여 탄력 개선도를 평가하였으며, coneometer(CM820 Courage+Khazaka electronic GmbH, Germany)를 이용하여 보습력을, 또한 설문을 이용하여 매끄러움, 화장할 때 화장이 잘 받는지 등의 여부를 판별하였다.After giving the products prepared in Examples 2 and Comparative Examples 4 to 6 in each tank and applying them once a day for 1 month, after 1 month, a replica was made using silicone and visiometer (SV500, Courage + Khazaka electronic GmbH, Germany) By measuring the depth of wrinkles by measuring the depth of wrinkles through image analysis using), the elasticity of the face area was measured by using a cutometer (SEM474, Courage + Khazaka electronic GmbH, Germany) that can measure skin elasticity. The degree of elasticity improvement was evaluated as compared with before application, and the moisturizing power was determined by using a coneometer (CM820 Courage + Khazaka electronic GmbH, Germany), and the questionnaire was used to determine whether the makeup was smooth and the makeup was well received.
3) 결과3) results
시험 결과는 표 8에 나타나 있다. 각각의 제품을 도포하기 전의 상태와 비교하여 도포 후에 피부가 개선된 정도를 %로 나타내어 평균을 구하였다.The test results are shown in Table 8. The degree of improvement of the skin after application was expressed in% as compared to the state before application of each product, and the average was obtained.
상기 표 8로부터 알 수 있는 바와 같이, 베타-1,3-글루칸과 인삼사포닌을 동시에 함유하는 O/W 제형의 외용제 조성물은 피부 주름 개선 및 탄력 증진등에 효과가 있음이 명백하다.As can be seen from Table 8, it is apparent that the external preparation composition of the O / W formulation containing beta-1,3-glucan and ginseng saponin at the same time is effective in improving skin wrinkles and enhancing elasticity.
이하, 상기한 시험예의 결과를 근거로 하여, 베타-1,3-글루칸과 인삼사포닌 을 동시에 함유함으로써, 피부노화 방지효과를 제공할 수 있는 여러 가지 제형의 화장료를 조성하여 제시한다. 그러나, 본 발명의 조성물이 하기의 예에만 한정되는 것은 아니다.Hereinafter, on the basis of the results of the above test examples, by simultaneously containing beta-1,3-glucan and ginseng saponin, to present a cosmetic composition of various formulations that can provide a skin anti-aging effect. However, the composition of the present invention is not limited only to the following examples.
<제형예 1> 유연화장수(스킨로션)<Formulation Example 1> Softening Cosmetic (Skin Lotion)
<제형예 2> 영양화장수(밀크로션)<Formulation Example 2> Nourishing Cosmetic Water (Milk Lotion)
<제형예 3> 영양크림Formulation Example 3 Nutrition Cream
<제형예 4> 마사지크림Formulation Example 4 Massage Cream
<제형예 5> 팩<Formulation Example 5> Pack
<제형예 6> 젤<Formulation Example 6> Gel
<제형예 7> 연고<Formulation Example 7> Ointment
<제형예 8> 국소투여용 약제(겔 연고제)<Formulation Example 8> Topical administration agent (gel ointment)
<제형예 9> 국소 투여용 약제(패취제)<Formulation example 9> The agent for topical administration (patch)
이상에서 설명한 바와 같이, 본 발명에 의해 제공되는 베타-1,3-글루칸과 인삼사포닌이 함유된 피부 외용제는 피부 주름 개선 및 피부 탄력을 개선하는 효과가 뛰어나고 피부노화를 방지하는 효과가 있다.As described above, the external preparation for skin containing beta-1,3-glucan and ginseng saponin provided by the present invention has an effect of improving skin wrinkles and improving skin elasticity and preventing skin aging.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990065695A KR100585613B1 (en) | 1999-12-30 | 1999-12-30 | External application composition containing ?-1,3-glucan and ginseng saponin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990065695A KR100585613B1 (en) | 1999-12-30 | 1999-12-30 | External application composition containing ?-1,3-glucan and ginseng saponin |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010065755A KR20010065755A (en) | 2001-07-11 |
KR100585613B1 true KR100585613B1 (en) | 2007-04-12 |
Family
ID=19632875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990065695A KR100585613B1 (en) | 1999-12-30 | 1999-12-30 | External application composition containing ?-1,3-glucan and ginseng saponin |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100585613B1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100867679B1 (en) * | 2001-08-14 | 2008-11-10 | 주식회사 참 존 | Natural liquid crystal composition and cosmetic composition containing it |
KR100423521B1 (en) * | 2001-08-29 | 2004-03-18 | 네비온 주식회사 | Cosmetic compositions containing panax ginseng polysaccharides |
KR100907086B1 (en) * | 2009-03-25 | 2009-07-09 | 김영춘 | Method of producing cosmetic patch comprising the fermented ginseng extracts |
KR101445258B1 (en) * | 2013-08-07 | 2014-10-02 | 서원대학교산학협력단 | Cosmetic composition containing red ginseng liquid with glucan fermented by mushroom mycelium |
CN104068021B (en) * | 2014-07-10 | 2016-05-11 | 王开运 | GL-B composition and the application in agricultural thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR830000141A (en) * | 1982-08-10 | 1983-03-25 | 와다 도키오 | Manual Lavera ink coating device |
JPH07138175A (en) * | 1993-11-17 | 1995-05-30 | Pola Chem Ind Inc | Oxygen of ginseng saponin |
JPH08291021A (en) * | 1995-04-25 | 1996-11-05 | Noevir Co Ltd | Solid-like oil-in-water type emulsified cosmetic |
JPH11171784A (en) * | 1997-12-09 | 1999-06-29 | Noevir Co Ltd | External preparation for skin |
KR19990076537A (en) * | 1998-03-24 | 1999-10-15 | 서경배 | "Preparation method of beta-1, 6-branch-beta-1, 3-glucan derived from agaric mushroom and external preparation composition containing beta-1, 6-branch-beta-1, 3-glucan prepared by this method |
-
1999
- 1999-12-30 KR KR1019990065695A patent/KR100585613B1/en not_active IP Right Cessation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR830000141A (en) * | 1982-08-10 | 1983-03-25 | 와다 도키오 | Manual Lavera ink coating device |
JPH07138175A (en) * | 1993-11-17 | 1995-05-30 | Pola Chem Ind Inc | Oxygen of ginseng saponin |
JPH08291021A (en) * | 1995-04-25 | 1996-11-05 | Noevir Co Ltd | Solid-like oil-in-water type emulsified cosmetic |
JPH11171784A (en) * | 1997-12-09 | 1999-06-29 | Noevir Co Ltd | External preparation for skin |
KR19990076537A (en) * | 1998-03-24 | 1999-10-15 | 서경배 | "Preparation method of beta-1, 6-branch-beta-1, 3-glucan derived from agaric mushroom and external preparation composition containing beta-1, 6-branch-beta-1, 3-glucan prepared by this method |
KR100295623B1 (en) * | 1998-03-24 | 2001-09-06 | 서경배 | A method for isolation of β-1,6-branched-β-1,3-glucan from Schizophyllum commune Fr. and compositions for cosmetic application containing β-1,6-branched-β-1,3-glucan obtained by the same |
Also Published As
Publication number | Publication date |
---|---|
KR20010065755A (en) | 2001-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111888284B (en) | Cosmetic composition | |
CA2749750C (en) | Skin care compositions and methods of use thereof | |
CN107072936A (en) | Topical compositions | |
CN105663018A (en) | Cosmetic composition | |
US20080160114A1 (en) | Composition of Skin External Application Containing Rose Extract and Epigallocatechin Gallate(Egcg) | |
CN103622852A (en) | Cosmetic composition | |
CN109350579B (en) | Whitening cosmetic additive, whitening skin-refreshing lotion and preparation method thereof | |
CN103037880A (en) | Composition containing paper mulberry extracts | |
CN109330954B (en) | Whitening skin brightening lotion, preparation method thereof and tyrosinase inhibitor | |
CN113081890A (en) | Essence with anti-sugar and anti-oxidation functions and preparation method thereof | |
US8216618B2 (en) | Cosmetic use of an Ophiopogon japonicus active principle | |
KR100361433B1 (en) | Anti-aging cosmetic compositions containing an Extract obtained from Panax ginseng | |
CN115517999A (en) | Anti-aging composition and application thereof in beauty and skin care | |
KR101574558B1 (en) | Cosmetic composition containing ginsenoside Rd, Rb2 and Bambusae Caulis in Taeniam extracts | |
JPH09255547A (en) | Skin preparation for external use | |
KR100585613B1 (en) | External application composition containing ?-1,3-glucan and ginseng saponin | |
CN111658587A (en) | Collagenase inhibitor composition, anti-aging water lotion and preparation method thereof | |
CN109453088B (en) | Whitening and firming cream, preparation method thereof and tyrosinase inhibitor | |
KR101587077B1 (en) | Composition containing fermentated opuntia humifusa showing biological activity of skin | |
KR102281606B1 (en) | A multifunctional cosmetic composition for elasticity, anti-wrinkle, inhibiting tyrosinase comprising peptide complex | |
KR101843976B1 (en) | Cosmetic composition comprising extract of geminated phaseolus radiatus fermented by aureobasidium pullulans | |
CN109363956B (en) | Application of ganoderma lucidum extract, whitening water lotion and preparation method thereof | |
KR101954632B1 (en) | External composition for skin containing germinated seeds of ginseng extract | |
KR102333132B1 (en) | Cosmetic Composition containing Frangipani Oil or Fermented Frangipani Oil | |
CN112870122A (en) | High-stability nano emulsion with light protection effect and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130429 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140418 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150430 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170329 Year of fee payment: 12 |
|
LAPS | Lapse due to unpaid annual fee |